V. Deburghgraeve

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial

Emmanuelle Le Page, D. Veillard, David Laplaud et al. · The Lancet · 2015 · 175 citations

Neurological Disorder, Medicine, Clinical Trials +6

Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients

Xavier Ayrignac, Clarisse Carra‐Dallière, Nicolas Menjot de Champfleur et al. · Brain · 2014 · 73 citations · Full text

Adult-onset Genetic Leukoencephalopathies, Mri Pattern-based Approach, Systematic Biological Screening +17

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study

Ayman Tourbah, Olivier Gout, Alain Vighetto et al. · CNS Drugs · 2018 · 37 citations · Full text

Choreic syndrome due to Hashimoto's encephalopathy

Grégory Taurin, Véronique Golfier, Jean‐François Pinel et al. · Movement Disorders · 2002 · 36 citations

Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?

J. Bonenfant, Emma Bajeux, V. Deburghgraeve et al. · European Journal of Neurology · 2016 · 35 citations